These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32598569)

  • 1. The Effects of Prolonged Exposure on Substance Use in Patients With Posttraumatic Stress Disorder and Substance Use Disorders.
    Peirce JM; Schacht RL; Brooner RK
    J Trauma Stress; 2020 Aug; 33(4):465-476. PubMed ID: 32598569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity.
    Badour CL; Flanagan JC; Gros DF; Killeen T; Pericot-Valverde I; Korte KJ; Allan NP; Back SE
    J Consult Clin Psychol; 2017 Mar; 85(3):274-281. PubMed ID: 28221062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving.
    Kaczkurkin AN; Asnaani A; Alpert E; Foa EB
    Behav Res Ther; 2016 Apr; 79():7-14. PubMed ID: 26905901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure.
    Jarnecke AM; Allan NP; Badour CL; Flanagan JC; Killeen TK; Back SE
    Addict Behav; 2019 Mar; 90():35-39. PubMed ID: 30355535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
    Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
    Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout.
    Szafranski DD; Snead A; Allan NP; Gros DF; Killeen T; Flanagan J; Pericot-Valverde I; Back SE
    Addict Behav; 2017 Oct; 73():30-35. PubMed ID: 28460246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
    Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
    Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention.
    Hien DA; Smith KZ; Owens M; López-Castro T; Ruglass LM; Papini S
    J Consult Clin Psychol; 2018 Oct; 86(10):810-819. PubMed ID: 30265040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders.
    Badour CL; Flanagan JC; Allan NP; Gilmore AK; Gros DF; Killeen T; Korte KJ; Brown DG; Kolnogorova K; Back SE
    J Trauma Stress; 2022 Apr; 35(2):546-558. PubMed ID: 34773928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders?
    Lancaster CL; Gros DF; Mullarkey MC; Badour CL; Killeen TK; Brady KT; Back SE
    Behav Cogn Psychother; 2020 Jan; 48(1):38-53. PubMed ID: 31010449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length.
    Mills AC; Badour CL; Korte KJ; Killeen TK; Henschel AV; Back SE
    J Trauma Stress; 2017 Apr; 30(2):166-172. PubMed ID: 28329434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotion dysregulation moderates the effect of cognitive behavior therapy with prolonged exposure for co-occurring PTSD and substance use disorders.
    Hien DA; Lopez-Castro T; Papini S; Gorman B; Ruglass LM
    J Anxiety Disord; 2017 Dec; 52():53-61. PubMed ID: 29049902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trauma-focused exposure therapy for chronic posttraumatic stress disorder in alcohol and drug dependent patients: A randomized controlled trial.
    Coffey SF; Schumacher JA; Nosen E; Littlefield AK; Henslee AM; Lappen A; Stasiewicz PR
    Psychol Addict Behav; 2016 Nov; 30(7):778-790. PubMed ID: 27786516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Exposure-Based Risk Reduction Through Family Therapy for Co-occurring Substance Use Problems and Posttraumatic Stress Disorder Symptoms Among Adolescents: A Randomized Clinical Trial.
    Danielson CK; Adams Z; McCart MR; Chapman JE; Sheidow AJ; Walker J; Smalling A; de Arellano MA
    JAMA Psychiatry; 2020 Jun; 77(6):574-586. PubMed ID: 32022827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of traumatic brain injury on treatment outcomes of Concurrent Treatment for PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) in veterans.
    Gros DF; Lancaster CL; Horner MD; Szafranski DD; Back SE
    Compr Psychiatry; 2017 Oct; 78():48-53. PubMed ID: 28803041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the research domain criteria framework to track domains of change in comorbid PTSD and SUD.
    Zambrano-Vazquez L; Levy HC; Belleau EL; Dworkin ER; Howard Sharp KM; Pittenger SL; Schumacher JA; Coffey SF
    Psychol Trauma; 2017 Nov; 9(6):679-687. PubMed ID: 28165268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaginal exposure processing during Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) therapy: Examination of linguistic markers of cohesiveness.
    Gandelman EM; Miller SA; Back SE
    J Trauma Stress; 2022 Apr; 35(2):682-693. PubMed ID: 34979039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes?
    Bountress KE; Badour C; Flanagan J; Gilmore AK; Back SE
    Psychol Trauma; 2018 Nov; 10(6):662-665. PubMed ID: 28771018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of substance use disorders: Effects on patients with higher or lower levels of PTSD symptoms.
    Wieferink CEM; de Haan HA; Dijkstra BAG; Fledderus M; Kok T
    Addict Behav; 2017 Nov; 74():122-126. PubMed ID: 28622616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice.
    Somohano VC; Rehder KL; Dingle T; Shank T; Bowen S
    J Dual Diagn; 2019; 15(4):233-242. PubMed ID: 31304887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.